Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates

Yazar: Kudgus, Rachel A., Bhattacharya, Resham, Mukherjee, Priyabrata
Yayımlandı Anticancer Agents Med Chem (2011)

Inorganic Nanoparticles in Cancer Therapy

Yazar: Bhattacharyya, Sanjib, Kudgus, Rachel A., Bhattacharya, Resham, Mukherjee, Priyabrata
Baskı/Yayın Bilgisi 2010

Tuning Pharmacokinetics and Biodistribution of a Targeted Drug Delivery System Through Incorporation of a Passive Targeting Component

Yazar: Kudgus, Rachel A., Walden, Chad A., McGovern, Renee M., Reid, Joel M., Robertson, J. David, Mukherjee, Priyabrata
Baskı/Yayın Bilgisi 2014

Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics

Yazar: Kudgus, Rachel A., Szabolcs, Annamaria, Khan, Jameel Ahmad, Walden, Chad A., Reid, Joel M., Robertson, J. David, Bhattacharya, Resham, Mukherjee, Priyabrata
Baskı/Yayın Bilgisi 2013

A Phase 1 Study of the c-Met Inhibitor, Tivantinib (ARQ197) in Children with Relapsed or Refractory Solid Tumors: A Children’s Oncology Group Study Phase 1 and Pilot Consortium Tri...

Yazar: Geller, James I., Perentesis, John P., Liu, Xiaowei, Minard, Charles G., Kudgus, Rachel A., Reid, Joel M., Fox, Elizabeth, Blaney, Susan M., Weigel, Brenda J.
Yayımlandı Pediatr Blood Cancer (2017)

A Study of Axitinib (INLYTA(™)), a VEGF Receptor Tyrosine Kinase Inhibitor, in Children and Adolescents with Recurrent or Refractory Solid Tumors: A Children’s Oncology Group Phase...

Yazar: Geller, James I., Fox, Elizabeth, Turpin, Brian, Goldstein, Stuart, Liu, Xiaowei, Minard, Charles G., Kudgus, Rachel A., Reid, Joel M., Berg, Stacey, Weigel, Brenda J.
Yayımlandı Cancer (2018)

Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits

Yazar: Roy Chowdhury, Uttio, Kudgus, Rachel A., Rinkoski, Tommy A., Holman, Bradley H., Bahler, Cindy K., Hann, Cheryl R., Reid, Joel M., Dosa, Peter I., Fautsch, Michael P.
Yayımlandı PLoS One (2020)

Nivolumab in children and young adults with relapsed/refractory solid tumors (ADVL1412): A Phase 1 / 2 Trial

Yazar: Davis, Kara L., Fox, Elizabeth, Merchant, Melinda S., Reid, Joel M., Kudgus, Rachel A., Liu, Xiaowei, Minard, Charles G., Voss, Stephan, Berg, Stacey L., Weigel, Brenda J., Mackall, Crystal L.
Yayımlandı Lancet Oncol (2020)

Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo

Yazar: Khan, Jameel Ahmad, Kudgus, Rachel A., Szabolcs, Annamaria, Dutta, Shamit, Wang, Enfeng, Cao, Sheng, Curran, Geoffry L., Shah, Vijay, Curley, Steven, Mukhopadhyay, Debabrata, Robertson, J. David, Bhattacharya, Resham, Mukherjee, Priyabrata
Baskı/Yayın Bilgisi 2011

A Phase 1 Study of Cabozantinib in Children and Adolescents with Recurrent or Refractory Solid Tumors, Including CNS Tumors: Trial ADVL1211, A Report from the Children’s Oncology G...

Yazar: Chuk, Meredith K., Widemann, Brigitte C., Minard, Charles G., Liu, Xiaowei, Kim, AeRang, Bernhardt, M. Brooke, Kudgus, Rachel A., Reid, Joel M., Voss, Stephan D., Blaney, Susan, Fox, Elizabeth, Weigel, Brenda J.
Yayımlandı Pediatr Blood Cancer (2018)

Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates

Yazar: Roy Chowdhury, Uttio, Kudgus, Rachel A., Holman, Bradley H., Rinkoski, Tommy A., Hann, Cheryl R., Bahler, Cindy K., McCloud, Eric, Appt, Susan E., Reid, Joel M., Dosa, Peter I., Fautsch, Michael P.
Yayımlandı J Ocul Pharmacol Ther (2021)

Phase I Clinical Trial of the Wee1 inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors. A COG Phase 1 Consortium Report (ADVL1312)

Yazar: Cole, Kristina A., Pal, Sharmistha, Kudgus, Rachel A., Ijaz, Heba, Liu, Xiaowei, Minard, Charles G., Pawel, Bruce, Maris, John M., Haas-Kogan, Daphne, Voss, Stephan, Berg, Stacey L., Reid, Joel M., Fox, Elizabeth, Weigel, Brenda J.
Yayımlandı Clin Cancer Res (2019)

ADVL1522: A Phase 2 Study of Lorvotuzumab Mertansine (IMGN901) in Children with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malig...

Yazar: Geller, James I, Pressey, Joseph G, Smith, Malcolm A, Kudgus, Rachel A, Cajaiba, Mariana, Reid, Joel M, Hall, David, Barkauskas, Donald A, Voss, Stephen D, Cho, Steve Y, Berg, Stacey L, Dome, Jeffrey S, Fox, Elizabeth, Weigel, Brenda J
Yayımlandı Cancer (2020)

Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth

Yazar: Saha, Sounik, Xiong, Xunhao, Chakraborty, Prabir K., Shameer, Khader, Arvizo, Rochelle R., Kudgus, Rachel A., Dwivedi, Shailendra Kumar Dhar, Hossen, Md. Nazir, Gillies, Elizabeth M., Robertson, J. David, Dudley, Joel T., Urrutia, Raul A., Postier, Russell G., Bhattacharya, Resham, Mukherjee, Priyabrata
Yayımlandı ACS Nano (2016)

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approac...

Yazar: DuBois, Steven G., Marachelian, Araz, Fox, Elizabeth, Kudgus, Rachel A., Reid, Joel M., Groshen, Susan, Malvar, Jemily, Bagatell, Rochelle, Wagner, Lars, Maris, John M., Hawkins, Randall, Courtier, Jesse, Lai, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Czarnecki, Scarlett, Tsao-Wei, Denice, Matthay, Katherine K., Mosse, Yael P.
Yayımlandı J Clin Oncol (2016)

Phase 2 Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

Yazar: DuBois, Steven G., Mosse, Yael P., Fox, Elizabeth, Kudgus, Rachel A., Reid, Joel M., McGovern, Renee, Groshen, Susan, Bagatell, Rochelle, Maris, John M., Twist, Clare J., Goldsmith, Kelly, Granger, M. Meaghan, Weiss, Brian, Park, Julie R., Macy, Margaret E., Cohn, Susan L., Yanik, Greg, Wagner, Lars, Hawkins, Randall, Courtier, Jesse, Lai, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Boucher, Najee, Czarnecki, Scarlett, Luo, Chunqiao, Tsao-Wei, Denice D., Matthay, Katherine K., Marachelian, Araz
Yayımlandı Clin Cancer Res (2018)

Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice

Yazar: Stojakovic, Andrea, Trushin, Sergey, Sheu, Anthony, Khalili, Layla, Chang, Su-Youne, Li, Xing, Christensen, Trace, Salisbury, Jeffrey L., Geroux, Rachel E., Gateno, Benjamin, Flannery, Padraig J., Dehankar, Mrunal, Funk, Cory C., Wilkins, Jordan, Stepanova, Anna, O’Hagan, Tara, Galkin, Alexander, Nesbitt, Jarred, Zhu, Xiujuan, Tripathi, Utkarsh, Macura, Slobodan, Tchkonia, Tamar, Pirtskhalava, Tamar, Kirkland, James L., Kudgus, Rachel A., Schoon, Renee A., Reid, Joel M., Yamazaki, Yu, Kanekiyo, Takahisa, Zhang, Song, Nemutlu, Emirhan, Dzeja, Petras, Jaspersen, Adam, Kwon, Ye In Christopher, Lee, Michael K., Trushina, Eugenia
Yayımlandı Commun Biol (2021)